Generation of Monoclonal Antibodies against Human Prion Proteins in PrP0/0 Mice
Tóm tắt
Prion diseases belong to a group of neurodegenerative disorders affecting humans and animals. The human diseases indude kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI). The pathogenic mechanisms of the prion diseases are not yet understood. Monoclonal antibodies provide valuable tools in the diagnosis, as well as in the basic research, of several diseases; however, monospecific antisera or monoclonal antibodies (mAbs) against human prion proteins were, until now, not available. We have developed an immunization protocol based on nucleic acid injection into nontolerant PrP0/0 mice. DNA or RNA coding for different human prion proteins including the mutated sequences associated with CJD, GSS, and FFI were injected into muscle tissue. Mice were primarily inoculated with DNA plasmids encoding the prion protein (PRNP) gene and boosted either with DNA, RNA, or recombinant Semliki Forest Virus particles expressing PRNP. Hybridomas were then prepared. Different mAbs against human prion proteins were obtained, and their binding behavior was analyzed by peptide enzyme-linked immunosorbent assay. Western blot, immunofluorescence, and immunoprecipita-tion. Their cross-reactivity with prion protein from other species was also determined. Our mAbs are directed against four different linear epitopes and may also recognize discontinuous regions of the native prion protein. These antibodies should allow us to address questions concerning the nature of the prion protein as well as the initiation and progression of prion diseases. Moreover, these mAbs can now be used for the diagnosis of prion diseases of humans and animals.
Tài liệu tham khảo
Prusiner SB. (1982) Novel proteinacious infectious particles cause scrapie. Science 216: 136–144.
Prusiner SB. (1991) Molecular biology of prion diseases. Science 252: 1515–1522.
Prusiner SB, and Hsiao KK. (1994) Human prion diseases. Ann. Neurol 35: 385–395.
Brown P, Goldfarb LG, Gajdusek CD. (1991) The new biology of spongiform encephalopathy: Infectious amyloidoses with a genetic twist. Lancet 337: 1019–1022.
Robakis NK, Devine-Gage EA, Jenkins EC, et al. (1986) Localization of a human gene homologous to the PrP gene on the p arm of chromosome 20 and detection of PrP-related antigens in normal human brains. Biochem. Biophys. Res. Commun. 140: 758–765.
Brown P, Cervenakowa L, Goldfarb LG, et al. (1994) Iatrogenic Creutzfeldt-Jakob disease: An example of the interplay between ancient genes and modern medicine. Neurology 44: 291–293.
Gibbs Jr CJ, Gajdusek DC, Asher DM, et al. (1968) Creutzfeldt-Jakob disease (spongiform encephalopathy): Transmission to the chimpanzee. Science 161: 388–389.
Brown P, Coker Vann M, Pomeroy K, et al. (1986) Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N. Engl. J. Med. 314: 547–551.
Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB. (1986) Seperation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 83: 2310–2314.
Gabizon R, Prusiner SB. (1990) Prion liposomes. Biochem. J. 266: 1–14.
Büeler H, Fischer M, Lang Y, et al. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577–582.
Büeler H, Aguzzi A, Sailer A, et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339–1347.
Kascsak RJ, Rubenstein R, Merz PA, et al. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virology 61: 3688–3693.
Barry RA, Vincent MT, Kent SBH, Hood LE, Prusiner SB. (1988) Characterization of prion proteins with monospecific antisera to synthetic peptides. J. Immunol. 140: 1188–1193.
Gabizon R, McKinley MP, Groth D, Prusiner SB. (1988) Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. U.S.A. 85: 6617–6621.
Serban D, Taraboulos A, DeArmond SJ, Prusiner SB. (1990) Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology 40: 110–117.
Prusiner SB, Groth D, Serban A, et al. (1993) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl. Acad. Sci. U.S.A. 90: 10608–10612.
Krasemann S, Groschup M, Hunsmann G, Bodemer W. (in press) Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of PrP0/0-mice. J. Immunol. Methods.
Krasemann S, Zerr I, Weber T, et al. (1995) Prion disease associated with a novel nine octapeptide repeat-insertion in the PRNP-gene. Mol. Brain Res. 34: 173–176.
Liljeström P, Garoff H. (1991) A new generation of animal cell expression vectors based on the Semliki Forest Virus replicon. Bio/Technology 9: 1356–1361.
Berglund P, Sjöberg M, Garoff H, Atkins GJ, Sheahan BJ, Liljeström P. (1993) Semliki Forest Virus expression system: Production of conditionally infectious recombinant particles. Bio/Technology 11: 916–920.
Davis HL, Michel M-L, Mancini M, Schleef M, Whalen RG. (1994) Direct gene transfer in skeletal muscle: Plasmid DNA-based immunization against the hepatitis B surface antigen. Vaccine 12: 1503–1509.
d’Albis A, Couteaux R, Janmot C, Mira J-C. (1989) Myosin isoform transitions in regeneration of fast and slow muscles during postnatal development of the rat. Dev. Biol. 135: 320–325.
Kearny JF, Radbruch A, Liesegang B, Rajewski K. (1979) A mouse myeloma cell line that has lost Immunglobulin expression but permits the construction of antibody-secreting hybridoma cell lines. J. Immunol. 123: 1548–1558.
Peters JH, Baumgarten H. (1990) Monoclonal Antibodies. 2nd Ed. Springer-Verlag, New York, pp. 150–157.
Pan K-M, Baldwin M, Nguyen J, et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 90: 10962–10966.
Ulmer JB, Donelly JJ, Parker SE, et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749.
Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199: 132–140.